Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation

被引:79
作者
Dentener, MA [1 ]
Vernooy, JHJ [1 ]
Hendriks, S [1 ]
Wouters, EFM [1 ]
机构
[1] Maastricht Univ, Dept Resp Med, NUTRIM, Maastricht, Netherlands
关键词
D O I
10.1136/thx.2003.020842
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Chronic inflammation and airway remodelling are characteristics of chronic obstructive pulmonary disease (COPD). Hyaluronan (HA) is an extracellular matrix compound with proinflammatory activity. HA levels in induced sputum from patients with COPD were measured and related to local inflammation. The expression of hyaluronan synthase 2 (HAS2) and hyaluronidase 2 (HYAL2) was analysed in lung tissue. Methods: Sputum was obtained from 18 patients with COPD (forced expiratory volume in 1 second (FEV1) 62% predicted (range 20-76)) and 14 healthy smokers. HA and inflammatory markers were measured using ELISA assays. Lung sections were obtained from five patients with severe COPD (FEV1 <30%) and from five smokers, and mRNA levels of HAS2 and HYAL2 were analysed by polymerase chain reaction. Results: HA levels were significantly higher in the sputum from patients with COPD than controls. The COPD population appeared to consist of two subpopulations with either high or moderate HA levels. The subgroup of patients with high HA levels had lower FEV1 than the moderate HA group. In addition, neutrophil influx and levels of interleukin-8, and the soluble tumour necrosis factor receptors R55 and R75 were significantly higher in patients with high HA levels than in those with moderate HA levels and controls. Semiquantitative analysis revealed enhanced expression of HYAL2 in lung tissue of patients with severe COPD compared with control subjects. Conclusion: These data indicate a relationship between HA levels, local inflammation and severity of disease, and suggest enhanced breakdown of HA in the lungs of patients with COPD.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 42 条
[1]   Induced sputum derives from the central airways - Confirmation using a radiolabeled aerosol bolus delivery technique [J].
Alexis, NE ;
Hu, SC ;
Zeman, K ;
Alter, T ;
Bennett, WD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (10) :1964-1970
[2]   EARLY CHANGES IN LUNG-TISSUE HYALURONAN (HYALURONIC-ACID) AND HYALURONIDASE IN BLEOMYCIN-INDUCED ALVEOLITIS IN HAMSTERS [J].
ANDERSON, B ;
SAMPSON, PM ;
OSMAN, M ;
GIANDOMENICO, A ;
TURINO, GM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (02) :284-288
[3]   Chronic obstructive pulmonary disease: molecular and cellular mechanisms [J].
Barnes, PJ ;
Shapiro, SD ;
Pauwels, RA .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (04) :672-688
[4]  
BOUMA MG, 1994, J IMMUNOL, V153, P4159
[5]  
Cantor JO, 1998, P SOC EXP BIOL MED, V217, P471
[6]   CD44 as a receptor for colonization of the pharynx by group A Streptococcus [J].
Cywes, C ;
Stamenkovic, I ;
Wessels, MR .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (08) :995-1002
[7]  
Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO
[8]  
2-J
[9]   Severity of airflow limitation is associated with severity of airway inflammation in smokers [J].
Di Stefano, A ;
Capelli, A ;
Lusuardi, M ;
Balbo, P ;
Vecchio, C ;
Maestrelli, P ;
Mapp, CE ;
Fabbri, LM ;
Donner, CF ;
Saetta, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (04) :1277-1285
[10]   AN ELISA PLATE BASED ASSAY FOR HYALURONAN USING BIOTINYLATED PROTEOGLYCAN-G1 DOMAIN (HA-BINDING REGION) [J].
FOSANG, AJ ;
HEY, NJ ;
CARNEY, SL ;
HARDINGHAM, TE .
MATRIX, 1990, 10 (05) :306-313